Vascepa is a prescription medication used to treat high levels of triglycerides in the blood. The eligibility requirements for Vascepa may vary depending on the specific health insurance plan and the prescribing doctor's discretion. According to the official Vascepa website [2], the medication is indicated as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (TG ≥500 mg/dL). However, the Kaiser Permanente formulary [3] states that Vascepa is approved for patients with triglyceride levels between 150-499 mg/dL who have persistent hypertriglyceridemia despite dietary modifications.

The eligibility for Vascepa may also depend on the patient's medical history and current medications. For example, the Drug Patent Watch website [1] notes that patients with a known hypersensitivity to Vascepa's active ingredient (icosapent ethyl) should not take the medication. Additionally, patients taking medications that contain omega-3 fatty acids or fish oil supplements should consult with their doctor before taking Vascepa.

In conclusion, the eligibility requirements for Vascepa may vary depending on the specific health insurance plan, the prescribing doctor's discretion, and the patient's medical history and current medications. Patients should consult with their doctor to determine if Vascepa is an appropriate treatment option for them.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.vascepa.com/
[3] https://healthy.kaiserpermanente.org/content/dam/kporg/final/documents/formularies/nw/vascepa-nw-en.pdf